Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
NCT01935089
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
HIV-1 Infection
Interventions
DRUG:
Pegylated Interferon alpha 2b
Sponsor
The Wistar Institute
Collaborators
[object Object]
[object Object]